{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:48:57Z","timestamp":1783648137261,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81360185"],"award-info":[{"award-number":["81360185"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shihezi University Research Project","award":["ZZZC201822A"],"award-info":[{"award-number":["ZZZC201822A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10735-021-09995-9","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T07:04:57Z","timestamp":1623049497000},"page":"823-838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fascin promotes the invasion of pituitary adenoma through partial dependence on epithelial\u2013mesenchymal transition"],"prefix":"10.1007","volume":"52","author":[{"given":"Hong","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"9995_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/en.2016-1967","volume":"158","author":"WL Bi","year":"2017","unstructured":"Bi WL, Greenwald NF, Ramkissoon SH et al (2017) Clinical identification of oncogenic drivers and copy-number alterations in pituitary tumors. Endocrinology 158:2284\u20132291. https:\/\/doi.org\/10.1210\/en.2016-1967","journal-title":"Endocrinology"},{"key":"9995_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000371806","volume":"101","author":"E Chatzellis","year":"2015","unstructured":"Chatzellis E, Alexandraki KI, Androulakis II et al (2015) Aggressive pituitary tumors. Neuroendocrinology 101:87\u2013104. https:\/\/doi.org\/10.1159\/000371806","journal-title":"Neuroendocrinology"},{"key":"9995_CR3","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/ijc.28199","volume":"133","author":"C Dai","year":"2013","unstructured":"Dai C, Zhang B, Liu X et al (2013) Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways. Int J Cancer 133:1982\u20131993. https:\/\/doi.org\/10.1002\/ijc.28199","journal-title":"Int J Cancer"},{"key":"9995_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA (2019) New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20:69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9995_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","volume":"54","author":"H Easwaran","year":"2014","unstructured":"Easwaran H, Tsai HC, Baylin SB (2014) Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 54:716\u2013727. https:\/\/doi.org\/10.1016\/j.molcel.2014.05.015","journal-title":"Mol Cell"},{"key":"9995_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3233\/cbm-190164","volume":"25","author":"AAM Foda","year":"2019","unstructured":"Foda AAM, Alam MS, Ikram N et al (2019) Spinal versus intracranial meningioma: expression of E-cadherin and fascin with relation to clinicopathological features. Cancer Biomark 25:333\u2013339. https:\/\/doi.org\/10.3233\/cbm-190164","journal-title":"Cancer Biomark"},{"key":"9995_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-019-1102-6","volume":"38","author":"R Gao","year":"2019","unstructured":"Gao R, Zhang N, Yang J et al (2019a) Long non-coding RNA ZEB1-AS1 regulates miR-200b\/FSCN1 signaling and enhances migration and invasion induced by TGF-\u03b21 in bladder cancer cells. J Exp Clin Cancer Res 38:111. https:\/\/doi.org\/10.1186\/s13046-019-1102-6","journal-title":"J Exp Clin Cancer Res"},{"key":"9995_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ymthe.2018.09.018","volume":"27","author":"W Gao","year":"2019","unstructured":"Gao W, Zhang C, Li W et al (2019b) Promoter methylation-regulated miR-145-5p inhibits laryngeal squamous cell carcinoma progression by targeting FSCN1. Mol Ther 27:365\u2013379. https:\/\/doi.org\/10.1016\/j.ymthe.2018.09.018","journal-title":"Mol Ther"},{"key":"9995_CR9","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/bjc.2014.453","volume":"111","author":"H Ghebeh","year":"2014","unstructured":"Ghebeh H, Al-Khaldi S, Olabi S et al (2014) Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K\/Akt pathway. Br J Cancer 111:1552\u20131561. https:\/\/doi.org\/10.1038\/bjc.2014.453","journal-title":"Br J Cancer"},{"key":"9995_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrm1682","volume":"6","author":"CW Gourlay","year":"2005","unstructured":"Gourlay CW, Ayscough KR (2005) The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 6:583\u2013589. https:\/\/doi.org\/10.1038\/nrm1682","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9995_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/neurosurgery\/16.cn_suppl_1.185","volume":"16","author":"J Hardy","year":"1969","unstructured":"Hardy J (1969) Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 16:185\u2013217. https:\/\/doi.org\/10.1093\/neurosurgery\/16.cn_suppl_1.185","journal-title":"Clin Neurosurg"},{"key":"9995_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/path.2894","volume":"224","author":"Y Hashimoto","year":"2011","unstructured":"Hashimoto Y, Kim DJ, Adams JC (2011) The roles of fascins in health and disease. J Pathol 224:289\u2013300. https:\/\/doi.org\/10.1002\/path.2894","journal-title":"J Pathol"},{"key":"9995_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00401-010-0642-9","volume":"119","author":"A Holsken","year":"2010","unstructured":"Holsken A, Buchfelder M, Fahlbusch R et al (2010) Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathol 119:631\u2013639. https:\/\/doi.org\/10.1007\/s00401-010-0642-9","journal-title":"Acta Neuropathol"},{"key":"9995_CR14","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1038\/ncomms8465","volume":"6","author":"FK Huang","year":"2015","unstructured":"Huang FK, Han S, Xing B et al (2015) Targeted inhibition of fascin function blocks tumour invasion and metastatic colonization. Nat Commun 6:7465. https:\/\/doi.org\/10.1038\/ncomms8465","journal-title":"Nat Commun"},{"key":"9995_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13058-017-0880-z","volume":"19","author":"HJ Hugo","year":"2017","unstructured":"Hugo HJ, Gunasinghe NPAD, Hollier BG et al (2017) Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Breast Cancer Res 19:86. https:\/\/doi.org\/10.1186\/s13058-017-0880-z","journal-title":"Breast Cancer Res"},{"key":"9995_CR16","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.biocel.2010.06.019","volume":"42","author":"A Jayo","year":"2010","unstructured":"Jayo A, Parsons M (2010) Fascin: a key regulator of cytoskeletal dynamics. Int J Biochem Cell Biol 42:1614\u20131617. https:\/\/doi.org\/10.1016\/j.biocel.2010.06.019","journal-title":"Int J Biochem Cell Biol"},{"key":"9995_CR17","first-page":"2635","volume":"35","author":"W Jia","year":"2015","unstructured":"Jia W, Zhu J, Martin TA et al (2015) Epithelial\u2013mesenchymal transition (EMT) markers in human pituitary adenomas indicate a clinical course. Anticancer Res 35:2635\u20132643","journal-title":"Anticancer Res"},{"key":"9995_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K et al (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610\u2013617; discussion 617\u2013618. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"key":"9995_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9995_CR20","first-page":"110","volume":"50","author":"D Larysz","year":"2012","unstructured":"Larysz D, Blamek S, Rudnik A (2012) Clinical aspects of molecular biology of pituitary adenomas. Folia Neuropathol 50:110\u2013117","journal-title":"Folia Neuropathol"},{"key":"9995_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1053\/j.gastro.2014.01.046","volume":"146","author":"A Li","year":"2014","unstructured":"Li A, Morton JP, Ma Y et al (2014) Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes. Gastroenterology 146:1386-1396.e1\u201317. https:\/\/doi.org\/10.1053\/j.gastro.2014.01.046","journal-title":"Gastroenterology"},{"key":"9995_CR22","first-page":"929","volume":"21","author":"Y Li","year":"2018","unstructured":"Li Y, Wang Y, Xu J et al (2018) Relationship between expression of fascin, Ki-67 and invasiveness in pituitary adenomas (in Chinese). Chin J Pract Nerv Dis 21:929\u2013934","journal-title":"Chin J Pract Nerv Dis"},{"key":"9995_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-019-2088-8","volume":"17","author":"B Li","year":"2019","unstructured":"Li B, Cheng J, Wang H et al (2019a) CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial\u2013mesenchymal transition. J Transl Med 17:336. https:\/\/doi.org\/10.1186\/s12967-019-2088-8","journal-title":"J Transl Med"},{"key":"9995_CR24","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.3892\/ol.2019.10847","volume":"18","author":"B Li","year":"2019","unstructured":"Li B, Zhu HB, Song GD et al (2019b) Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial-to-mesenchymal transition. Oncol Lett 18:4651\u20134658. https:\/\/doi.org\/10.3892\/ol.2019.10847","journal-title":"Oncol Lett"},{"key":"9995_CR25","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1242\/dev.071209","volume":"139","author":"J Lim","year":"2012","unstructured":"Lim J, Thiery JP (2012) Epithelial\u2013mesenchymal transitions: insights from development. Development (Cambridge, England) 139:3471\u20133486. https:\/\/doi.org\/10.1242\/dev.071209","journal-title":"Development (Cambridge, England)"},{"key":"9995_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.mce.2015.10.021","volume":"419","author":"C Liu","year":"2016","unstructured":"Liu C, Gao H, Cao L et al (2016) The role of FSCN1 in migration and invasion of pituitary adenomas. Mol Cell Endocrinol 419:217\u2013224. https:\/\/doi.org\/10.1016\/j.mce.2015.10.021","journal-title":"Mol Cell Endocrinol"},{"key":"9995_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"9995_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4161\/cib.3.3.11556","volume":"3","author":"LM Machesky","year":"2010","unstructured":"Machesky LM, Li A (2010) Fascin: invasive filopodia promoting metastasis. Commun Integr Biol 3:263\u2013270. https:\/\/doi.org\/10.4161\/cib.3.3.11556","journal-title":"Commun Integr Biol"},{"key":"9995_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MAJ.0b013e3182707108","volume":"346","author":"X Mao","year":"2013","unstructured":"Mao X, Chen D, Wu J et al (2013) Differential expression of fascin, E-cadherin and vimentin: proteins associated with survival of cholangiocarcinoma patients. Am J Med Sci 346:261\u2013268. https:\/\/doi.org\/10.1097\/MAJ.0b013e3182707108","journal-title":"Am J Med Sci"},{"key":"9995_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-17-0933","volume":"178","author":"A McCormack","year":"2018","unstructured":"McCormack A, Dekkers OM, Petersenn S et al (2018) Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. Eur J Endocrinol 178:265\u2013276. https:\/\/doi.org\/10.1530\/EJE-17-0933","journal-title":"Eur J Endocrinol"},{"key":"9995_CR31","doi-asserted-by":"publisher","first-page":"15147","DOI":"10.1074\/jbc.M807834200","volume":"284","author":"I Molina-Ortiz","year":"2009","unstructured":"Molina-Ortiz I, Bartolom\u00e9 RA, Hern\u00e1ndez-Varas P et al (2009) Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP\/p120ctn-dependent inactivation of RhoA. J Biol Chem 284:15147\u201315157. https:\/\/doi.org\/10.1074\/jbc.M807834200","journal-title":"J Biol Chem"},{"key":"9995_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2020.1758088","author":"G Qian","year":"2020","unstructured":"Qian G, Xu J, Shen X et al (2020) BP-1-102 and silencing of fascin-1 by RNA interference inhibits the proliferation of mouse pituitary adenoma AtT20 cells via the signal transducer and activator of transcription 3\/fascin-1 pathway. Int J Neurosci. https:\/\/doi.org\/10.1080\/00207454.2020.1758088","journal-title":"Int J Neurosci"},{"key":"9995_CR33","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1097\/IGC.0000000000001077","volume":"27","author":"AM Richmond","year":"2017","unstructured":"Richmond AM, Blake EA, Torkko K et al (2017) Fascin is associated with aggressive behavior and poor outcome in uterine carcinosarcoma. Int J Gynecol Cancer 27:1895\u20131903. https:\/\/doi.org\/10.1097\/IGC.0000000000001077","journal-title":"Int J Gynecol Cancer"},{"key":"9995_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/17446651.2017.1312341","volume":"12","author":"A Sav","year":"2017","unstructured":"Sav A, Rotondo F, Syro LV et al (2017) Selective molecular biomarkers to predict biologic behavior in pituitary tumors. Expert Rev Endocrinol Metab 12:177\u2013185. https:\/\/doi.org\/10.1080\/17446651.2017.1312341","journal-title":"Expert Rev Endocrinol Metab"},{"key":"9995_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s40291-019-00411-3","volume":"23","author":"EC Tampaki","year":"2019","unstructured":"Tampaki EC, Tampakis A, Nonni A et al (2019) Combined fascin-1 and MAP17 expression in breast cancer identifies patients with high risk for disease recurrence. Mol Diagn Ther 23:635\u2013644. https:\/\/doi.org\/10.1007\/s40291-019-00411-3","journal-title":"Mol Diagn Ther"},{"key":"9995_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1741-7015-11-52","volume":"11","author":"VY Tan","year":"2013","unstructured":"Tan VY, Lewis SJ, Adams JC et al (2013) Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis. BMC Med 11:52. https:\/\/doi.org\/10.1186\/1741-7015-11-52","journal-title":"BMC Med"},{"key":"9995_CR37","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3171\/jns.1984.61.5.0814","volume":"61","author":"CB Wilson","year":"1984","unstructured":"Wilson CB (1984) A decade of pituitary microsurgery. The Herbert Olivecrona lecture. J Neurosurg 61:814\u2013833. https:\/\/doi.org\/10.3171\/jns.1984.61.5.0814","journal-title":"J Neurosurg"},{"key":"9995_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.critrevonc.2017.11.010","volume":"121","author":"SHM Wong","year":"2018","unstructured":"Wong SHM, Fang CM, Chuah L-H et al (2018) E-cadherin: its dysregulation in carcinogenesis and clinical implications. Crit Rev Oncol Hematol 121:11\u201322. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.11.010","journal-title":"Crit Rev Oncol Hematol"},{"key":"9995_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10528-017-9794-9","volume":"55","author":"S Wu","year":"2017","unstructured":"Wu S, Gu Y, Huang Y et al (2017a) Novel biomarkers for non-functioning invasive pituitary adenomas were identified by using analysis of microRNAs expression profile. Biochem Genet 55:253\u2013267. https:\/\/doi.org\/10.1007\/s10528-017-9794-9","journal-title":"Biochem Genet"},{"key":"9995_CR40","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00432-017-2408-4","volume":"143","author":"X Wu","year":"2017","unstructured":"Wu X, Ma W, Zhou Q et al (2017b) AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases. J Cancer Res Clin Oncol 143:1947\u20131957. https:\/\/doi.org\/10.1007\/s00432-017-2408-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"9995_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/cbf.1750","volume":"29","author":"P Xing","year":"2011","unstructured":"Xing P, Li JG, Jin F et al (2011) Fascin, an actin-bundling protein, promotes breast cancer progression in vitro. Cell Biochem Funct 29:303\u2013310. https:\/\/doi.org\/10.1002\/cbf.1750","journal-title":"Cell Biochem Funct"},{"key":"9995_CR42","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.3748\/wjg.v17.i40.4470","volume":"17","author":"YF Xu","year":"2011","unstructured":"Xu YF, Yu SN, Lu ZH et al (2011) Fascin promotes the motility and invasiveness of pancreatic cancer cells. World J Gastroenterol 17:4470\u20134478. https:\/\/doi.org\/10.3748\/wjg.v17.i40.4470","journal-title":"World J Gastroenterol"},{"key":"9995_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fendo.2019.00007","volume":"10","author":"Q Yang","year":"2019","unstructured":"Yang Q, Li X (2019) Molecular network basis of invasive pituitary adenoma: a review. Front Endocrinol (Lausanne) 10:7. https:\/\/doi.org\/10.3389\/fendo.2019.00007","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-021-09995-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-021-09995-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-021-09995-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T05:13:41Z","timestamp":1627622021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-021-09995-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9995"],"URL":"https:\/\/doi.org\/10.1007\/s10735-021-09995-9","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients or their close relatives provided written informed consent for the collection of samples and subsequent research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patients or their close relatives provided written informed consent for the collection of samples and subsequent research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Ethics Committee of the First Affiliated Hospital, Shihezi University School of Medicine approval to carry out the study within its facilities (IORG No:2019-100-1).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}